|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.79(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,005,861 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2019-09-13 |
4 |
S |
$67,515.00 |
$305,640,405 |
D/D |
(4,527) |
759 |
|
- |
|
Buechler Kenneth F |
Director |
|
2019-09-11 |
4 |
S |
$68.86 |
$275,421 |
D/D |
(4,000) |
50,433 |
|
- |
|
Buechler Kenneth F |
Director |
|
2019-09-11 |
4 |
OE |
$13.25 |
$53,000 |
D/D |
4,000 |
54,433 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2019-09-11 |
4 |
S |
$68.61 |
$984,880 |
D/D |
(14,354) |
5,191 |
|
- |
|
Gibson Karen |
SVP, IS & Bus. Transformation |
|
2019-09-11 |
4 |
OE |
$25.55 |
$366,745 |
D/D |
14,354 |
19,545 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-09-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,407 |
19,543 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-09-11 |
4 |
S |
$70.00 |
$390,250 |
D/D |
(5,575) |
16,257 |
|
- |
|
Borkar Ratan S |
SVP, Intl Comm Operations |
|
2019-09-11 |
4 |
OE |
$23.41 |
$152,421 |
D/D |
5,575 |
21,768 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-09-10 |
4 |
S |
$65.00 |
$571,870 |
D/D |
(8,798) |
5,790 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-09-10 |
4 |
OE |
$15.40 |
$135,489 |
D/D |
8,798 |
14,226 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-08-30 |
4 |
S |
$65.40 |
$33,354 |
D/D |
(510) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-08-30 |
4 |
OE |
$15.19 |
$7,747 |
D/D |
510 |
301,952 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-08-29 |
4 |
S |
$64.28 |
$2,953,400 |
D/D |
(45,948) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-08-29 |
4 |
OE |
$15.19 |
$697,950 |
D/D |
45,948 |
347,390 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-08-28 |
4 |
S |
$58.30 |
$1,472,075 |
D/D |
(25,250) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-08-28 |
4 |
OE |
$15.19 |
$383,548 |
D/D |
25,250 |
326,692 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-07-29 |
4 |
S |
$57.78 |
$1,258,968 |
D/D |
(21,789) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-07-29 |
4 |
OE |
$15.19 |
$330,975 |
D/D |
21,789 |
323,231 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-06-28 |
4 |
S |
$60.06 |
$207,868 |
D/D |
(3,461) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-06-28 |
4 |
OE |
$15.19 |
$52,573 |
D/D |
3,461 |
304,903 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-06-26 |
4 |
S |
$57.25 |
$1,445,613 |
D/D |
(25,250) |
301,442 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-06-26 |
4 |
OE |
$12.63 |
$368,602 |
D/D |
25,250 |
326,692 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2019-06-18 |
4 |
S |
$57.16 |
$743,046 |
D/D |
(13,000) |
9,598 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2019-06-18 |
4 |
OE |
$15.40 |
$225,905 |
D/D |
13,000 |
22,598 |
|
- |
|
Kroll Werner |
SVP, R&D |
|
2019-05-27 |
4 |
D |
$54.42 |
$118,091 |
D/D |
(2,170) |
19,769 |
|
- |
|
1127 Records found
|
|
Page 12 of 46 |
|
|